| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/02/2004 | WO2004047758A3 Methods of therapy and diagnosis using targeting of cells that express p2y10 |
| 12/02/2004 | WO2004046345A3 Use of hmgb fragments as anti-inflammatory agents |
| 12/02/2004 | WO2004042064A3 Disorders of lipid metabolism |
| 12/02/2004 | WO2004037198A3 Antibody-mediated induction of tumor cell death |
| 12/02/2004 | WO2004034993A3 Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor |
| 12/02/2004 | WO2004032825A3 Use of 2,3 alkylcarbonyloxybenzoic acids in the treatment of anthrax |
| 12/02/2004 | WO2004031359A3 Method for regulating expression genes |
| 12/02/2004 | WO2004027020A3 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 12/02/2004 | WO2004009797A3 Protein modification and maintenance molecules |
| 12/02/2004 | WO2004007693A3 Human immunosuppressive protein |
| 12/02/2004 | WO2003104256A3 THE CaR RECEPTOR AS A MEDIATOR OF MIGRATORY CELL CHEMOTAXIS AND/OR CHEMOKINESIS |
| 12/02/2004 | WO2003095667A3 Autoimmune conditions and nadph oxidase defects |
| 12/02/2004 | WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof |
| 12/02/2004 | WO2003084478A3 Antisense modulation of hmgi-c expression |
| 12/02/2004 | WO2003083079A8 Bone generation by gene therapy |
| 12/02/2004 | WO2003072709A3 Variant tat proteins and methods for use thereof |
| 12/02/2004 | WO2003069307A3 Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer |
| 12/02/2004 | WO2003063767A3 Rsv proteins, antibodies, compositions, methods and uses |
| 12/02/2004 | WO2003048326A3 Methods and materials relating to novel polypeptides and polynucleotides |
| 12/02/2004 | WO2003039452A3 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| 12/02/2004 | WO2003025119A3 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies |
| 12/02/2004 | WO2003022205A3 Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions |
| 12/02/2004 | WO2002051981A3 Defects in periaxin associated with myelinopathies |
| 12/02/2004 | US20040244062 Use of protein inhibitors as antithrombotic agents |
| 12/02/2004 | US20040243316 Crystallographic structure of the androgen receptor ligand binding domain |
| 12/02/2004 | US20040243097 Antiproliferative drug and delivery device |
| 12/02/2004 | US20040242859 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 12/02/2004 | US20040242853 Glp-1 exendin-4 peptide analogs and uses thereof |
| 12/02/2004 | US20040242852 Bifunctional chelating agent for actinium |
| 12/02/2004 | US20040242850 Monoclonal antibody for use as diagnostic agent in monitoring nervous system development |
| 12/02/2004 | US20040242847 Monoclonal antibody for use as a preventive and/or remedy cancer, inflammation, hormone and blood diseases; immunotherapy |
| 12/02/2004 | US20040242845 Methods and compositions comprising supramolecular antigenic constructs and antibodies elicited against them |
| 12/02/2004 | US20040242844 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine |
| 12/02/2004 | US20040242842 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 12/02/2004 | US20040242687 Thrombus/thrombogenesis inhibitors |
| 12/02/2004 | US20040242682 Compositions comprising arginine and nitrates |
| 12/02/2004 | US20040242676 Method of mitigating the adverse effects of IL-2 |
| 12/02/2004 | US20040242606 Anti-cancer cyclopenta (g)quinazoline compounds |
| 12/02/2004 | US20040242536 controlled-release mixtures of plant extracts, gelation polymers and drugs such as ximelagatran, used for prophylaxis of cardiovascular disorders |
| 12/02/2004 | US20040242529 Vector encoding inactivated telomerase for treating cancer |
| 12/02/2004 | US20040242525 Method for promoting gonadal growth in an animal |
| 12/02/2004 | US20040242519 Mixing DNA or RNA antiproliferative agents that hybridize with the mRNA that codes for the Ki-67 nuclear protein with a carrier; antitumor, antiarthritic, and antiinflammatory agents, antiallergens, wound healing agents, autoimmune diseases, transplant rejection suppression |
| 12/02/2004 | US20040242518 Influenza therapeutic |
| 12/02/2004 | US20040242516 Antisense modulation of apolipoprotein(a) expression |
| 12/02/2004 | US20040242515 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy home-ostasis |
| 12/02/2004 | US20040242509 Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate |
| 12/02/2004 | US20040242505 Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
| 12/02/2004 | US20040242491 For use in the treatment of gout and related symptoms or in the amelioration of symptoms related to a high level of uric acid such as muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, or as a dietary supplement |
| 12/02/2004 | US20040242490 CLK-peptide and SLK-peptide |
| 12/02/2004 | US20040242489 Method for improving stability of a bone-connecting implant |
| 12/02/2004 | US20040242488 Peptides having same amino acid sequence and same anti-microbial activity as those of Phylloseptins which are isolated from the skin of Phyllomedusa hypochondrialis; the 19-residue anti-microbial peptides are cationic and based on their primary structure, all peptides can fitted to an amphiphilic a-helix |
| 12/02/2004 | US20040242487 Identifying a subject in need of inhibiting appetite or weight gain and administering an effective amount of an antagonist of melanocyte concentrating hormone (MCH) to subject, wherein antagonist binds an MCH receptor |
| 12/02/2004 | US20040242486 for promoting the survival, growth, proliferation, or maintenance of neurons in an injured but not severed spinal cord; promoting axonal regeneration, inhibiting the effects of scar tissue formation; antiapoptotic agents |
| 12/02/2004 | US20040242485 Compositions and methods for the amelioration of leptin resistance |
| 12/02/2004 | US20040242484 Specific polypeptides, useful as nematocides |
| 12/02/2004 | US20040242483 Molecules, compositions, methods and kits for applications associated with flaviviruses |
| 12/02/2004 | US20040242482 Methods for altering fate of a cell, tissue or organ type by simultaneously changing the activation state of the Notch pathway and one or more cell fate control gene pathways; use in cell replacement therapy to repopulate lost cell populations and help in regeneration of diseased and/or injured tissues |
| 12/02/2004 | US20040242481 Use of hmgb1 for the activation of dendritic cells |
| 12/02/2004 | US20040242480 Method for treating coumarin-induced hemorrhage |
| 12/02/2004 | US20040242479 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 12/02/2004 | US20040242478 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 12/02/2004 | US20040242476 Peptide and analogs thereof having an amino acid sequence corresponding to the second extracellular domain of a mammalian occludin; may be administered orally or parenterally |
| 12/02/2004 | US20040242475 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 12/02/2004 | US20040242474 High density lipoprotein-reactive peptides |
| 12/02/2004 | US20040242472 Use of artemin, a member of the gdnf ligand family |
| 12/02/2004 | US20040242470 Molecules secreted by cells and which are capable of inhibiting proliferation of those and/or other cells; for prophylaxis and therapy of proliferative disorders, including, atherosclerosis and cancer |
| 12/02/2004 | US20040242469 Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof |
| 12/02/2004 | US20040242468 For therapy of arthritis |
| 12/02/2004 | US20040242467 Contacting an aqueous solution of the lipopeptide antibiotic and a divalent metal ion with an organic solvent, thereby extracting the lipopeptide antibiotic into the organic solvent; andcontacting the organic solvent extract of the lipopeptide antibiotic with acid |
| 12/02/2004 | US20040242466 improves adhesion of human dermal fibroblasts and promotes the cellular growth of human epidermal keratinocytes; produced by Pseudoalteromonas antartica; for topical or oral administration; veterinary medicine; for treatment of hair, skin, and nails |
| 12/02/2004 | US20040242464 Blood substitute for human/mammal transfusions in vivo; comprises lysis/centrifugation of erythrocytes; cross-linking |
| 12/02/2004 | US20040242463 Compositions for stabilizing oxygen-labile species |
| 12/02/2004 | US20040242462 Detecting that individual's Tob gene, transcript and/or protein and comparing with normal Tob gene, transcript and/or protein, differences present indicating that the probability of that individual suffering from amnesia |
| 12/02/2004 | US20040242461 Modulators of telomere stability |
| 12/02/2004 | US20040242460 Using fatty acid, storage stable |
| 12/02/2004 | US20040242458 VP1 of foot-and-mouth disease virus |
| 12/02/2004 | US20040242457 Use of anti-glaucoma drugs to treat visual defects associated with the use of a GABAergic agent |
| 12/02/2004 | US20040241854 Mammalian cells comprising rna sequences directed towards gene which codes transcript for swedish double amyloid precursor protein mutation or a transcript for tau gene product for use in posttranscriptional gene silencing and treatment of alzheimer's disease; gene therapy |
| 12/02/2004 | US20040241853 Introducing one or more mutations into a template double-stranded polynucleotide via hybridization, replication and amplification of random genomic double stranded and heterozygous oligonucleotides sequences; genomics and directed evolution |
| 12/02/2004 | US20040241845 Mammalian staufen and use thereof |
| 12/02/2004 | US20040241844 Oligonucleotides for controlling expression of c-reactive protein for use in treatment of infection, autoimmune, diabetic or inflammatory disease |
| 12/02/2004 | US20040241843 Antisense modulation of interleukin 12 p40 subunit expression |
| 12/02/2004 | US20040241826 Mycobacterial antigens expressed during latency |
| 12/02/2004 | US20040241818 Assay |
| 12/02/2004 | US20040241817 Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function |
| 12/02/2004 | US20040241807 Interleukin-1 related gene and protein |
| 12/02/2004 | US20040241806 G-CSF polypeptides and conjugates |
| 12/02/2004 | US20040241805 Cell surface binding protein for use in treatment, diagnosis and prevention of cancer, inflammation, autoimmunity, allergy, asthma and nervous system disorders |
| 12/02/2004 | US20040241804 Novel polypeptide, a cDNA encoding the same, and use of it |
| 12/02/2004 | US20040241803 25 human secreted proteins |
| 12/02/2004 | US20040241800 Vascular endothelial growth factor dimers |
| 12/02/2004 | US20040241798 ADH7 nucleotides |
| 12/02/2004 | US20040241758 CD 30 ligand |
| 12/02/2004 | US20040241756 Methods and means of histone methylation |
| 12/02/2004 | US20040241754 Identifying modulators which intefere with association of ephrin receptor and its ligand or ephrin and postsynaptic density disc-large zo-1 protein (PDZ) for use in treatment of neurodegenerative diseases |
| 12/02/2004 | US20040241731 Methods of producing nucleic acid ligands |
| 12/02/2004 | US20040241689 Using immunoglobulins to bind cell surface receptor and prevent microbial infection; bactericides; immunotherapy; transport protein inhibition |
| 12/02/2004 | US20040241686 Vector comprising nucleotide sequences coding oncogenic protein for use in identication of modulators for treatment and prevention of cell proliferative and metabolic disorders |
| 12/02/2004 | US20040241682 Cancer |
| 12/02/2004 | US20040241673 Non-cytotoxic pap mutants |